Skip to content
Viagra LabsViagra Labs
Vidalista CT 20 mg
Vidalista CT 20 mg

Vidalista CT (tadalafil)

Vidalista CT is described as a 20 mg chewable tadalafil tablet associated with Centurion Laboratories.

Active ingredient
tadalafil
Formulation
Chewable tablet
Company in catalogue
Centurion Laboratories Pvt Ltd

Vidalista CT is described as a 20 mg chewable tadalafil tablet associated with Centurion Laboratories. Its formulation is the relevant distinction from the ordinary Vidalista tablet record.

What distinguishes this product

Do not expand the CT suffix into claims not supported by the actual leaflet. The chewable presentation needs its own excipient and administration information; the ingredient name alone does not supply those details.

Product record

Record type
Indian branded generic
Treatment area in this directory
Erectile dysfunction (ED)
Active ingredient
tadalafil
Formulation in the cited record
Chewable tablet
Source-listed strengths
20 mg
Company in the cited record
Centurion Laboratories Pvt Ltd (Company attributed by the source catalogue)
Manufacturing information
A specific manufacturing site is not established by the cited catalogue record. Consult the country-specific label and pack.
Market evidence
Global reference; exact market authorization not established by this catalogue import
Storage reported by source
Store below 30°C Check the supplied leaflet for the exact presentation.
Catalogue reviewed

Catalogue attributes describe the named product as reported by the source. Listed strengths are identification details, not dosing instructions. Ingredient evidence and company identity are useful signals; local product authorization is a separate question.

Ingredient references

These references cover the active ingredients. They do not verify every named brand, pack or formulation listed on this page.

How the ingredients fit treatment

Tadalafil is a PDE5 inhibitor with a longer duration of action than sildenafil. Its documented ED regimens include daily and as-needed treatment, using different prescribed strengths. A catalogue strength alone does not identify which regimen is appropriate.

Ingredient guidance and safe use

Read the ingredient guidance alongside the leaflet for the actual product. A different brand, strength or dosage form may need different instructions.

Do not combine a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing. Tell the treating team which medicine you took and when.

Commonly reported effects of oral PDE5 medicines include headache, flushing, indigestion and nasal congestion; the pattern varies by ingredient and product. The cited ingredient information covers adverse effects and restrictions in more detail.

Interactions and urgent symptoms · Understanding formulations · Finding a local medicine record

Related product records